Estimated Financials
| 50,000 Lives | ||||
|---|---|---|---|---|
| Drug Type | Brand | Generic | Specialty | All Claims |
| Total Pharmacy Revenue | $26,828,290 | $8,434,490 | $17,866,001 | $53,128,780 |
| Number of Prescriptions | 77,668 | 432,664 | 2,668 | 513,000 |
| Gross Profit Margin* | $3,989,520 | $2,358,746 | $2,256,629 | $8,604,894 |
| 75,000 lives | ||||
|---|---|---|---|---|
| Drug Type | Brand | Generic | Specialty | All Claims |
| Total Pharmacy Revenue | $40,242,435 | $12,651,735 | $26,799,001 | $79,693,170 |
| Number of Prescriptions | 116,502 | 648,996 | 4,001 | 769,500 |
| Gross Profit Margin* | $5,984,280 | $3,538,119 | $3,384,943 | $12,907,341 |
* Revenue split between Cient & Rx Med Solutions
Creating Value for your System
Market capitalization values of PBM’s are 10-12X EBITDA
| 50,000 lives | |
|---|---|
| Gross Profit Margin | $8,604,894 |
| Overhead expense (50%) | $4,302,447 |
| EBITDA | $4,302,447 |
| Market CAP (10-12X EBITDA) | |
| Market Value (Low End) | $43,024,471 |
| Market Value (High End) | $51,629,365 |
| 75,000 lives | |
|---|---|
| Gross Profit Margin | $12,907,341 |
| Overhead expense (50%) | $6,453,671 |
| EBITDA | $6,453,671 |
| Market CAP (10-12X EBITDA) | |
| Market Value (Low End) | $64,536,707 |
| Market Value (High End) | $77,444,048 |